Evidence map›Paper›PMID 31231490›Full record

ArticleIranian journal of basic medical sciences2019

Effects of Lactobacillus

Peyman Ranji, Shahram Agah, Zahra Heydari, Mohammad Rahmati-Yamchi, Ali Mohammad Alizadeh

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Probiotics Cancer Interaction, Prevention, and Therapy.Immunity, inflammation and disease · 2026
    Review
  6. Review
  7. Foods (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Association betweenBiomolecules & therapeutics · 2024
    Article
  12. Article
  13. Iranian journal of basic medical sciences · 2022
    Review
  14. Review
  15. Supplementation withInternational journal of molecular sciences · 2021
    Article
  16. Probiotics in Cancer.Frontiers in oncology · 2021
    Review
  17. Review
  18. Role ofMicroorganisms · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Peyman RanjiCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Shahram AgahColorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
Zahra HeydariCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Rahmati-YamchiDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Ali Mohammad AlizadehCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRIran University of Medical Sciences · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe preclinical reports have shown that specific probiotics like MATERIALS AND

methodsThirty-six male BALB/c mice were equally shared into 4 groups; (i) health with routine dietary foods without any treatment, (ii) azoxymethane (AOM)-induced mice colon cancer with common dietary foods, (iii) and (iv) AOM-induced mice colon cancer with oral consumption of

resultsOral consumption of

conclusion

Indexed as

Colon cancerLeptin receptorMiceProbioticVitamin D receptor

Identifiers

PMID31231490
PMCPMC6570744
OpenAlexW2941829754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.